Zai Lab Ltd
NASDAQ:ZLAB

  • LAST PRICE
    17.3300
  • TODAY'S CHANGE (%)
    -0.1900 (-1.0845%)
  • Bid / Lots
    17.0000/ 1
  • Ask / Lots
    17.5800/ 4
  • Open / Previous Close
    17.1300 / 17.5200
  • Day Range
    16.9550
    17.6000
  • 52 Week Range
    13.4800
    32.6000
  • Volume
    475,314

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Biotechnology Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
ZLAB
Zai Lab Ltd
1.7B
-5.0x
---
MRVI
Maravai LifeSciences Holdings Inc
1.7B
-7.2x
---
KNSA
Kiniksa Pharmaceuticals Ltd
1.3B
219.1x
---
GLPG
Galapagos NV
1.6B
49.6x
---
DVAX
Dynavax Technologies Corp
1.4B
224.8x
---
VCYT
Veracyte Inc
1.7B
-23.2x
---
As of 2024-06-29

Company Information

Zai Lab Ltd is a holding company mainly engaged in the biopharmaceutical field. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including oncology, autoimmune and infectious diseases fields. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include Niraparib (ZL-2306), ZL-2103, ZL-1101 and others.

Contact Information

Headquarters
4560 Jinke Road, Bldg. 1, 4/F, PudongSHANGHAI, SHA, China 201210
Phone
216-163-2588
Fax
216-163-2570

Executives

Chairman of the Board, Chief Executive Officer, Co-Founder
Du Ying
President, Chief Operating Officer
Joshua Smiley
Chief Financial Officer
Yajing Chen
President, Head of Global Research and Development
Rafael Amado
President, Head - Global Development of Neuroscience, Autoimmune and Infectious Diseases
Harald Reinhart

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$1.7B
Revenue (TTM)
$291.1M
Shares Outstanding
99.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.05
EPS
$-3.50
Book Value
$8.19
P/E Ratio
-5.0x
Price/Sales (TTM)
5.9
Price/Cash Flow (TTM)
---
Operating Margin
-126.21%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.